Drug firm Wockhardt plans to roll out two vaccines within a year from its UK-based facility as part of a tie-up with Serum Institute of India, a top company official said
The DCGI had approved Covovax for a restricted use in emergency situations in adults on December 28, 2021 and for those in the 12-17 age group, subject to certain conditions, on March 9.
"We are ready to manufacture and stockpile qHPV at our own risk in view of early availability of this life-saving vaccine for the citizens of our country," said Prakash Kumar Singh.
The first indigenous human papillomavirus (HPV) vaccine was launched by Union Home Minister Amit Shah on January 24 in the presence of Serum Institute of India (SII) CEO Adar Poonawalla and its Director of Government and...
The move comes after an application was submitted by Prakash Kumar Singh, director, Government and Regulatory Affairs, at Serum Institute of India (SII) to DCGI on September 27 seeking permission to export the vaccine...
Musk, who has made a successful $44 billion acquisition bid for Twitter, had in the past asked India to reduce import duties to sell Tesla electric cars but the government has insisted on local manufacturing
Serum Institute's made-in-India HPV vaccine "CERVAVAC" was launched by Union Home Minister Amit Shah on January 24, in presence of the Pune-based firm's CEO Adar Poonawalla and Prakash Kumar Singh, its Director-Government...
Recalling that they could not meet the commitment of exporting vaccines in the first quarter of 2021 due to "so much noise from public and the opposition", Poonawalla on Tuesday also pitched for a global pact for vaccine...
India's drug regulator had approved Covovax for restricted use in emergency situations in adults on December 28 and in the 12 to 17 years age group subject...
The EUA application was submitted on March 22 by Prakash Kumar Singh, Director of Government and Regulatory Affairs at the Serum Institute of India (SII).
The collaboration between Wockhardt UK and Serum Life Sciences UK Ltd will help create a considerable number of employment opportunities along with the...
The Drugs Controller General Of India (DCGI) had approved Covovax for restricted use in emergency situations in adults on December 28. The vaccine is yet to be...
Solicitor General Tushar Mehta told this to a bench comprising Justices L Nageswara Rao and B R Gavai that was hearing a matter in which issues including...
The two-dose vaccine uses adenoviruses that infect chimpanzees to carry the gene responsible for the spike protein of the novel coronavirus.
The Covovax/Novavax vaccine has recently received Emergency Use Listing (EUL) with the World Health Organisation (WHO), Emergency Use Authorization (EUA) in...
The government had recently permitted the export of 2 crore doses of COVID-19 vaccine Covovax to Indonesia produced in India by SII, as the jab had not yet...
PM Narendra Modi will be meeting representatives of Indian Covid-19 vaccine manufactures including Serum Institute of India, Bharat Biotech and Dr Reddy's...
.png)
The company’s CEO Adar Poonawalla said the company would be able to export 20 to 30 million Covid-19 vaccine doses in November this year.
Prime Minister Scott Morrison's office said the Therapeutic Goods Administration (TGA) has advised that Coronavac (Sinovac) and Covishield should be considered...
The Pune-based SII has already supplied 12 crore doses of the COVID-19 vaccine in August, they said.
It has been communicated to the state that these doses should be administered at private hospitals only.
_.jpg)
SII Chairman Dr Cyrus Poonawalla was speaking at the event where he received the Lokmanyat Tilak National Award instituted by the Lokmanya Tilak Trust here.
The efficacy of this approach has not been proven in field trials involving thousands of participants, Cyrus Poonawalla said
The Department of Biotechnology under the Ministry of Science and Technology has launched 'Mission COVID Suraksha- the Indian COVID-19 Vaccine Development...
'Vaccination drive is going on smoothly. It will get more accelerated in the coming days with the ramping up of production by four more Indian companies,' said...
